Somewhat Positive News Coverage Somewhat Unlikely to Affect MYnd Analytics (MYND) Share Price

News coverage about MYnd Analytics (NASDAQ:MYND) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. MYnd Analytics earned a news sentiment score of 0.12 on Accern’s scale. Accern also gave news headlines about the company an impact score of 45.5824555337946 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Separately, Maxim Group reaffirmed a “buy” rating and set a $18.00 target price on shares of MYnd Analytics in a research note on Tuesday, September 26th.

Shares of MYnd Analytics (NASDAQ:MYND) opened at $3.92 on Wednesday. MYnd Analytics has a fifty-two week low of $2.80 and a fifty-two week high of $9.45.

MYnd Analytics (NASDAQ:MYND) last released its earnings results on Monday, August 14th. The company reported ($0.62) earnings per share for the quarter. The business had revenue of $0.04 million during the quarter.

TRADEMARK VIOLATION NOTICE: “Somewhat Positive News Coverage Somewhat Unlikely to Affect MYnd Analytics (MYND) Share Price” was originally published by Week Herald and is owned by of Week Herald. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of international trademark & copyright law. The correct version of this news story can be read at https://weekherald.com/2017/11/15/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-mynd-analytics-mynd-share-price.html.

About MYnd Analytics

MYnd Analytics, Inc, formerly CNS Response, Inc, is a predictive analytics company. The Company has developed a decision support tool to help physicians reduce trial and error treatment in mental health, and provide personalized care to patients. The Company provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder (PTSD) and other non-psychotic disorders.

Insider Buying and Selling by Quarter for MYnd Analytics (NASDAQ:MYND)

Receive News & Ratings for MYnd Analytics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYnd Analytics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply